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Background and aims: We aimed to identify clusters of metabolic syndrome (MetS) components, risky for
extremely high intima-media thickness.
Methods: We studied 41,513 volunteers (men and women) from eleven cohorts worldwide, participating
in the MARE (Metabolic syndrome and Artery REsearch) Consortium.
Results: Speciﬁc clusters of MetS components - high triglycerides-high blood pressure-abdominal
obesity (TBW), low HDL cholesterol-high blood pressure-abdominal obesity (HBW), high glucose-high
blood pressure-abdominal obesity (GBW) - were accompanied by a 50e90% signiﬁcantly greater likeli-
hood of presenting extremely high intima-media thickness (via ultrasound of carotid artery, CCA IMT),
after controlling for age, sex, smoking, non-HDL cholesterol, and presence of diabetes mellitus. This
likelihood is comparable to the effect of being 7e8 years older or of being a cigarette smoker or of having
non-HDL cholesterol 50 mg/dl higher.loelefante@rocketmail.com (A. Scuteri).
rved.
A. Scuteri et al. / Atherosclerosis 255 (2016) 11e1612Conclusions: The consistent association of speciﬁc clusters of MetS components with extremely thick
(older) large artery cross-culturally suggests that identiﬁcation of those clusters in clinical practice will
facilitate a personalized health care and a better e i.e. more healthy and cost-effective - prevention of
major cardiovascular (CV) events.
© 2016 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The common carotid artery intima-media thickness (CCA IMT)
has been reported to be associated with cardiovascular (CV) risk
factors [1] and arterial remodelling [2]. Subsequently, population
studies identiﬁed CCA IMT as a predictor of CV events, independent
of blood pressure, lipids, and glucose levels [3e5]. Ultrasound im-
aging of CCA IMT is a combined measure of intima and media
layers. Over time, there has been a transformation of CCA IMT from
a novel and independent CV risk marker into a proxy of arterial
aging [6]. In fact, IMT increases from 20 years to 80 years of age [7]
and this increase is faster in men than in women [8]. CCA IMT is
currently considered expression of Target Organ Damage (TOD) in
International Guidelines for treatment of hypertensive subjects [9].
The early identiﬁcation of subjects with accelerated arterial aging,
or Early Vascular Aging (EVA) [10], i.e. with arterial parameters
typically observed at older (chronological) age, seems critical to
implement effective prevention of CV events and optimal health-
care resource allocation. This has particular relevance in the context
of growing evidence of a more complex association of traditional
CV risk factors with older artery [11].
We selected metabolic syndrome (MetS), a well conceptualized
and operationalized model of clustering of multiple CV risk factors,
to investigate the impact of speciﬁc cluster of MetS components on
extremely high intima-media thickness (CCA IMT). The identiﬁca-
tion of risky-clusters linked to MetS will facilitate a personalized
approach to prevention of CV events and CV-related disability.2. Patients and methods
2.1. The MARE consortium
In 2012, the original MARE (Metabolic syndrome and Artery
REsearch) Consortium was established as a collaboration among
eleven European and one American centers studying population-
based cohorts to identify any cross-cultural differences in clus-
tering of MetS altered components and associations with arterial
aging; to disentangle the speciﬁc role of genes and lifestyle factors
(and their interactions) on the clinical presentation of MetS and on
the CV risk attributable to MetS and to develop new strategies to
prevent CV events through identiﬁcation of lifestyle changes (see
reference [12] for more details).
In 2014 and 2015, additional participating cohorts joined the
MARE Consortium, providing that new data on the MetS compo-
nents and on arterial properties became available for the recruited
subjects. Currently, approximately 75,000 subjects from 22 cohorts
worldwide are participating in the MARE Consortium.
Each cohort had been approved by local Institutional Review
Board or Ethic Committee and each subject gave informed consent.
All studies in the MARE Consortium adhere to the principles of the
Declaration of Helsinki and Title 45, U.S. Code of Federal Regula-
tions, Part 46, Protection of Human Subjects, Revised November 13,
2001, effective December 13, 2001.
The cohorts participating in the present analysis are brieﬂy
described in Supplementary Materials.3. Deﬁnition of the metabolic syndrome
The Third Report of the National Cholesterol Education Program
Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (ATP III) [13] deﬁned the MetS as an alteration
in three or more of the following ﬁve components: abdominal
obesity (W), high triglycerides (T), low HDL cholesterol (H),
elevated blood pressure (systolic or diastolic) (B), and elevated
fasting glucose (G). The following cut-off values are used to deﬁne
each altered component: triglycerides 150 mg/dl HDL cholesterol
<40 mg/dl for men or <50 mg/dl for women, blood pressure 130/
85 mmHg, fasting glucose 110 mg/dl, and waist circumference
>102 cm for men or >88 cm for women. For Asian subjects, an
elevated waist circumference is deﬁned as 80 cm for women and
90 cm for men [14]. In 2009, a revised deﬁnition of MetS has been
proposed [14]. In this deﬁnition the cut-off values to deﬁne
elevated fasting glucose were lowered to 100 mg/dl, and ethnic
speciﬁc cut-offs have been deﬁned for waist circumference [14].
To allow comparability with previous studies, we adopted the
original ATP II deﬁnition of MetS for primary analyses and the
revised deﬁnition of MetS for secondary conﬁrmatory analyses.
BecauseMetS is deﬁned by the presence of three ormore altered
components, subjects with MetS may have diagnosed based on
different combinations of the individual components of MetS.
3.1. CCA IMT measurements
High-resolution B-mode carotid ultrasonography was per-
formed for measurement of CCA IMT. The subject lay in the supine
position in a dark, quiet room. The right CCA was examined with
the head tilted slightly upward in the midline position. The trans-
ducer was manipulated so that the near and far walls of the CCA
were parallel to the transducer footprint and the lumen diameter
was maximized in the longitudinal plane. A region 1.5 cm proximal
to the carotid bifurcation was identiﬁed, and the IMT of the far wall
was evaluated as the distance between the luminal-intimal inter-
face and the medial-adventitial interface. IMT was measured in
areas without plaques or calciﬁcation (at least 1 mm distance from
the plaque shoulder, if plaque was present).
Some details of the IMT measurement differed across Centers as
illustrated in Table 1.
3.2. Statistical analysis
All analyses were performed using the SAS package for Win-
dows (9.1 Version Cary, NC, US). ANOVA analysis followed by
Bonferroni test was adopted to compare means amongst subgroups
of subjects. Least square means (±standard error, SEM) were
calculated with ANCOVA analysis in order to compare CCA IMT
values across clusters of MetS components, after controlling for
covariates (age, sex, non-HDL cholesterol levels, current smoking,
presence of diabetes mellitus, and study center for CCA IMT).
Multivariable logistic regression analyses were used to identify
which clusters of MetS components were signiﬁcantly associated
with extremely high intima-media thickness. Extremely high
Table 1
Characteristics of the MARE cohorts included according to measurement of CCA IMT.
Asklepios LitHiR Rotterdam SardiNIA SHIP BLSA Namwon Dong-gu Kingmen
Aging Study
MDC-CV Moscow
Country Belgium Lithuania The Netherlands Italy Germany USA South Korea South Korea Taiwan Sweden Russia
N 2522 1417 3733 6049 2395 759 10262 9092 1305 3692 287
Years CCA
IMT
measured
2002- 2007e2015 1990e93 2001e2004
(baseline)
1997e2001 (baseline) 1958- 2004e2007 2007e2010 1992e1993 2012e2013
Site measured Near &
far wall
Left & right
Far wall
Left & right
Near & far wall
Left & right
Far wall
Right
Far wall
Left & right
Far wall
Right at
end-diastole
Far wall
Left & right
Far wall
Left & right
Far wall
Right at
end-diastole
Far wall
Right
Far wall
Left & right
Device VIVID 7, GE
Vingmed
Ultrasound,
Horten,
(Norway).
High-
resolution
echo-tracking
technology
(Art.Lab,
Esaote
Europe B.V.,
Maastricht,
the
Netherlands)
Duplex scanner
(ATL UltraMark IV)
High-resolution
Bmode carotid
ultrasonography
was performed by
use of a
lineararray5-
to 7.5- MHz
transducer (HDI
3500-
ATLUltramark Inc)
B-Modeultrasonography
was performed using
a 5 MHz linear array
transducer with an
axial resolution of less
than 0.5 mm and
a high resolution
instrument (Diasonics VST
Gateway, Santa Clara,
California, USA).
5- to 10-MHz
transducer
(Ultramark
9 HDI,
Advanced
Technology
Laboratories,
Inc)
B-mode
ultrasound
scanners
(SONOACE 9900;
Medison, Seoul,
Korea) with
an electrical
linear array
transducer
(7.5 MHz).
B-mode
ultrasound
scanners
(SONOACE
9900; Medison,
Seoul, Korea)
with an
electrical linear
array transducer
(7.5 MHz).
Hewlett-
Packard SONOS
500 U
(Hewlett-Packard,
Andover,
MA) 7-MHz
vascular probe
High-
resolution
B-mode 17,
5-MHz
linear-type
probe
(PHILIPS
iU22)
Table 2
Characteristic of cohorts participating the MARE Consortium with available IMT measurements.
Asklepios LitHiR Rotterdam SardiNIA SHIP BLSA Namwon Dong-gu Kingmen Aging Study MDC-CV Moscow
Country Belgium Lithuania The Netherlands Italy Germany USA South Korea South Korea Taiwan Sweden Russia
N 2522 1417 3733 6049 2395 759 10262 9092 1305 3692 287
Age (years) 46 ± 6 55 ± 6 72 ± 7 44 ± 17 61 ± 9 66 ± 14 62 ± 8 65 ± 8 52 ± 13 72 ± 6 52 ± 13
Women (%) 48.5 34.2 42.0 57.5 48.9 48.2 60.5 59.9 46.4 59.3 66.9
Waist (cm) 87.1 ± 12.7 105.3 ± 11.4 93.5 ± 11.4 84.8 ± 13.1 93.6 ± 12.7 91.6 ± 12.0 86.1 ± 8.4 88.1 ± 8.6 85.0 ± 9.0 92.3 ± 12.5 89.7 ± 15.2
BMI (Kg/m2) 25.8 ± 4.3 31.9 ± 5.1 26.8 ± 39.5 25.4 ± 4.7 28.5 ± 4.6 27.0 ± 4.7 24.3 ± 3.0 24.4 ± 2.9 24.8 ± 3.0 26.9 ± 4.4 27.3 ± 5.1
Glucose (mg/dl) 91.4 ± 12.3 112.2 ± 25.5 106.9 ± 26.6 90.1 ± 23.6 108.0 ± 37.3 94.8 ± 17.4 104.9 ± 24.6 109.7 ± 25.2 98.8 ± 15.7 110.9 ± 26.2 103.7 ± 25.9
Total cholesterol (mg/dl) 216.5 ± 36.6 258.9 ± 52.8 225.0 ± 37.8 208.6 ± 42.2 235.2 ± 45.4 191.1 ± 38.4 189.3 ± 36.9 201.3 ± 39.6 197.5 ± 36.7 201.0 ± 41.3 219.8 ± 44.4
nonHDL cholesterol (mg/dl) 153.6 ± 38.0 209.1 ± 51.2 171.4 ± 37.9 145.3 ± 38.8 179.6 ± 45.2 134.3 ± 36.1 142.8 ± 34.8 150.5 ± 37.0 147.3 ± 36.4 146.6 ± 37.9 172.9 ± 45.3
HDL cholesterol (mg/dl) 63.6 ± 17.2 50.0 ± 12.3 53.9 ± 15.4 64.2 ± 14.9 55.8 ± 17.2 58.6 ± 16.5 47.6 ± 11.9 51.6 ± 11.9 50.9 ± 12.9 55.2 ± 16.7 47.2 ± 12.0
Triglycerides (mg/dl) 109.8 ± 71.1 195.2 ± 113.4 133.7 ± 64.0 85.2 ± 52.7 173.9 ± 105.3 104.3 ± 61.7 154.8 ± 97.3 140.8 ± 87.4 123.0 ± 85.2 56.6 ± 30.7 65.6 ± 44.1
SBP (mmHg) 126.9 ± 14.1 139.7 ± 15.6 143.4 ± 21.2 125.9 ± 18.5 144.4 ± 21.3 121.5 ± 15.6 126.0 ± 18.4 123.4 ± 16.9 138.9 ± 23.7 135.8 ± 17.3 125.4 ± 16.6
DBP (mmHg) 80.0 ± 10.0 86.0 ± 9.7 75.2 ± 11.1 77.6 ± 10.5 86.0 ± 11.3 66.4 ± 9.1 80.4 ± 10.2 74.4 ± 10.2 87.9 ± 14.6 75.7 ± 8.7 78.2 ± 10.3
MetS (%) 9.0 62.2 29.8 6.8 30.1 14.4 39.2 34.8 32.4 22.2 28.3
Hypertension (%) 28.8 58.3 55.1 29.0 69.6 16.6 39.8 44.7 50.3 70.0 25.8
Diabetes mellitus (%) 1.6 23.6 13.5 4.9 18.3 12.0 12.2 20.0 5.4 17.7 26.8
Antihypertensive
medication (%)
10.5 N/A N/A 9.5 75.4 4.7 21.6 35.7 e 56.8 N/A
CCA IMT (mm) 0.60 ± 0.11 0.67 ± 0.10 0.87 ± 0.15 0.55 ± 0.11 0.79 ± 0.18 0.59 ± 0.08 0.74 ± 0.14 0.72 ± 0.15 1.03 ± 0.26 0.92 ± 0.22 0.76 ± 0.20
CCA IMT 95th % (mm) 0.81 0.84 1.15 0.77 1.10 0.72 0.97 1.00 1.50 1.30 1.11
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A. Scuteri et al. / Atherosclerosis 255 (2016) 11e1614intima-media thickness was deﬁned based upon the 95th percen-
tile of CCA IMT distribution within each cohort. Age, sex, non-HDL
cholesterol levels, current smoking status, and presence of diabetes
mellitus were introduced as covariates.
A two-sided p value < 0.05 indicated statistical signiﬁcance.4. Results
Complete data were available for 41,513 subjects (18,501 men
and 22,932 women) from eleven cohorts, whose characteristics are
brieﬂy summarized in Tables 1 and 2. MetS had an overall preva-
lence of 27.3% (11,325 subjects) and unexpectedly indicated a
greater prevalence in Asian cohorts.
Average values and 95th percentile for CCA IMT showed wide
differences across studies and the acquisition methods of CCA IMT
varied at each study site (year, equipment, ECG-gating, etc), as
illustrated in Table 1. This greater variability across studies further
supports the choice of the study-speciﬁc 95th percentile in CCA IMT
to identify extremely high intima-media thickness. Notably, the
interaction term between study site and cluster of MetS component
was not signiﬁcant at ANCOVA analysise indicating that the impact
of speciﬁc clusters of MetS components on CCA IMT did not
signiﬁcantly differ across the sites.
By adopting the within cohort 95th CCA IMT percentile sub-
group to deﬁne subjects with extremely high intima-media thick-
ness, after controlling for age, sex, smoking, non-HDL cholesterol,
and presence of diabetes mellitus, speciﬁc clusters of MetS com-
ponents were relatively more associated with the occurrence of
extreme values of CCA IMT (Table 3 left columns). Counter-
intuitively, when affected subjects were compared to those
without MetS, not all the clusters of MetS components were asso-
ciated with extremely high intima-media thickness. Speciﬁc clus-
ters (for instance TBW, HBW, GBW)were accompanied by a 50e90%
signiﬁcantly greater likelihood of presenting extremely thick ar-
teries e which was comparable to that associated with the simul-
taneous alteration in all the ﬁve MetS components. This likelihood
is comparable to the effect of being 7e8 years older or being aTable 3
Speciﬁc clusters of MetS components as determinants of extremely high intima-media t
Prevalence within Prevalence of extrem
high CCA IMT (%)
Whole
population (%)
Subjects with
MetS (%)
Age (per 10 years of age)
Male sex
Current smoking
Diabetes mellitus
Non-HDL cholesterol
(per 40 mg/dl)
Control (no MetS) 69.9 e 4.4
TBW 2.7 9.0 6.1
HBW 3.2 10.8 7.1
HTW 3.3 11.0 4.2
HTB 1.2 4.1 9.5
HTBW 3.4 11.4 7.5
GBW 3.1 10.4 5.8
GTBW 1.8 6.0 8.5
GHBW 1.7 5.6 9.5
GHTBW 2.3 7.8 8.8
Other MetS clusters 7.2 24.0 6.7
TBW,high trilycerides-high blood pressure-abdominal obesity; HBW,low HDL choleste
glycerides - abdominal obesity; HTB,low HDL cholesterol - high triglycerides - high bloo
abdominal obesity; GBW,high glucose-high blood pressure-abdominal obesity; GT
GHBW,high glucose-low HDL cholesterol - high blood pressure-abdominal obesity; GH
abdominal obesity.smoker or having a non-HDL cholesterol 50mg/dl higher.When the
presence of diabetes mellitus was not included amongst the cova-
riates, the impact of MetS cluster including glucose on CCA IMTwas
greater (Table 3 right columns).
Conﬁrmatory analyses conducted with the 2009 harmonizaed
MetS deﬁnition [14] yielded ﬁndings similar to what reported for
ATP III MetS deﬁnition, as illustrated in Table 4.5. Discussion
The metabolic syndrome (MetS) remains a controversial entity
and its conceptual construct has been criticized [15,16]. The main
and fundamental criticism concerning the CV risk associated with
CV is that the whole is not greater than the sum of the parts. In
other terms, a large number of scientists suggested that current
evidence does not support clinical usefulness of MetS diagnosis, as
it does not imply any action that would otherwise be ignored or
missed (not in the therapeutic approach, not in the presence of CV
greater risk, not in patient's attitude towards a healthier lifestyle
and/or a greater adherence to therapy). Notably, they still recom-
mend that more research is needed to understand the cause of risk-
factor clustering rather than pursuing MetS diagnosis [15].
A major limitation to the current approach to MetS is that, by
deﬁnition, any cluster of three or more of its components is sufﬁ-
cient to diagnose MetS. In other terms, the unproven assumption is
that any combination of three MetS components carries a similar
CV risk. However, this point has scarcely been investigated [16]. We
ﬁrstly reported that speciﬁc clusters of altered MetS components -
rather than MetS per se - were associated with accelerated arterial
aging in the SardiNIA Study [7]. The observation was conﬁrmed for
arterial stiffness, indexed as Pulse Wave Velocity, in multiple co-
horts from different countries participating the MARE Consortium
[17]. Speciﬁcally, MetS clusters TBW, GBW, and GTBW were asso-
ciated with extremely stiff large artery [17]. Notably, only speciﬁc
clusters of altered MetS components conferred a higher risk of CV
events in the Framingham Study [18].
The present study identiﬁed speciﬁc clusters of MetShickness as compared to Control (no MetS) subjects.
ely Controlling for age, sex, diabetes
mellitus, non-HDL cholesterol,
smoking, and study site
Controlling for age,
sex, non-HDL cholesterol,
smoking, and study site
OR 95% CI p < OR 95% CI p <
1.78 1.70e1.86 0.0001 1.78 1.70e1.86 0.0001
1.78 1.61e1.98 0.0001 1.81 1.63e2.01 0.0001
1.22 1.13e1.30 0.0001 1.21 1.02e1.43 0.0001
2.17 1.80e2.61 0.0001\ — — e
1.24 1.18e1.30 0.0001 1.24 1.18e1.30 0.0001
1.0 1.0
1.38 1.05e1.81 1.33 1.02e1.75
1.94 1.54e2.45 1.87 1.48e2.35
1.15 0.87e1.51 1.11 0.84e1.46
1.69 1.21e2.36 1.63 1.16e2.27
1.95 1.57e2.42 1.89 1.52e2.35
1.41 1.13e1.77 1.74 1.40e2.14
1.24 0.92e1.68 1.59 1.19e2.13
1.59 1.19e2.12 1.99 1.51e2.63
1.46 1.12e1.90 1.89 1.47e2.43
0.95 0.80e1.15 1.21 1.02e1.43
rol-high blood pressure-abdominal obesity; HTW,low HDL cholesterol - high tri-
d pressure; HTBW, low HDL cholesterol - high triglycerides - high blood pressure-
BW,high glucose-high triglycerides - high blood pressure-abdominal obesity;
TBW,high glucose-low HDL cholesterol - high triglycerides - high blood pressure-
Table 4
Likelihood of extremely high intima-media thickness as compared to Control (no MetS) subjects,following adjustment for age, sex, diabetes mellitus, non-HDL cholesterol,
smoking, and study site,according to speciﬁc clusters of components of ATP II [13] (left columns) or harmonized deﬁnition of MetS [14] (right columns).
ATP III deﬁnition Harmonized deﬁnition
OR 95% CI p< OR 95% CI p<
Age (per 10 years of age) 1.78 1.70e1.86 0.0001 1.78 1.70e1.86 0.0001
Male sex 1.78 1.61e1.98 0.0001 1.78 1.61e1.98 0.0001
Current smoking 1.22 1.13e1.30 0.0001 1.22 1.13e1.30 0.0001
Diabetes mellitus 2.17 1.80e2.61 0.0001 2.17 1.80e2.61 0.0001
Non-HDL cholesterol (per 40 mg/dl) 1.24 1.18e1.30 0.0001 1.24 1.18e1.30 0.0001
Control (no MetS) 1.0 1.0
TBW 1.38 1.05e1.81 1.47 1.01e2.15
HBW 1.94 1.54e2.45 1.99 1.46e2.73
HTW 1.15 0.87e1.51 1.29 0.91e1.83
HTB 1.69 1.21e2.36 2.19 1.46e3.29
HTBW 1.95 1.57e2.42 2.39 1.82e3.14
GBW 1.41 1.13e1.77 1.31 1.08e1.58
GTBW 1.24 0.92e1.68 1.21 0.93e1.59
GHBW 1.59 1.19e2.12 1.47 1.14e1.89
GHTBW 1.46 1.12e1.90 1.31 1.03e1.68
Other MetS clusters 0.95 0.80e1.15 0.97 0.84e1.12
Legend: as in Table 3.
A. Scuteri et al. / Atherosclerosis 255 (2016) 11e16 15components (for instance, TBW, HBW, HTBW, and GBW) that are
consistently associated with extremely thick large artery (CCA IMT)
across cohorts. This association is independent of age, sex, and
other established CV risk factors. Thus, it is plausible that the as-
sociation with greater arterial wall thickness is not exclusively
driven by the number of altered MetS components, but rather by
the selective combination of speciﬁc cluster of MetS components.
The MARE Consortium included several population-based
studies from different countries around the world. Average CCA
IMT values differed across studies (Table 2). This may be also
attributable to heterogeneity in the techniques of CCA IMT acqui-
sition and measurement (Table 1). We have aimed to avoid most of
this “noise” by adopting the within-each cohort 95th percentile to
deﬁne extremely thick arteries.
Our ﬁndings may have attained statistical signiﬁcance by
chance. Yet, the MARE Consortium included a very large popula-
tion, that, together with the consistent ﬁndings that only selected
clusters of MetS components are associated with older arteries,
suggest that chance per se is unlikely a plausible explanation for the
reported observations.
Another possibility is that the association of speciﬁc clusters of
MetS components with arterial wall thickness is driven by a greater
prevalence of diabetes mellitus in those clusters. In fact, endothelial
dysfunction is observable in diabetic subjects prior to metabolic
alterations [19]. Endothelial dysfunction and decreased nitric oxide
bioavailability promote blood pressure increase [20], greater CCA
IMT [21], and vascular complication in diabetic subjects [22].
Nonetheless, adjustment for diabetes mellitus reduced the
magnitude but did not change the signiﬁcance of the odds ratio of
the association between the speciﬁc MetS cluster and extremely
high CCA IMT.
In these regards, amajor limitation of the current study design is
represented by the possibility to explore pathophysiological
mechanisms that may support the ﬁndings with a biological
interpretation.
However, our study conﬁrms that MetS can no longer be
regarded as a unique syndrome, impacting equally on large arteries,
and, thus, on a greater CV risk [2e5,17,18]. Additional research is
needed to characterize pathophysiological cascades linking speciﬁc
cluster of components of currently deﬁned MetS to older artery.
In conclusion, the consistent association of speciﬁc clusters of
MetS components with extremely high intima-media thickness
(older large arteries) cross-culturally suggests that identiﬁcation ofthose clusters in clinical practice may facilitate identiﬁcation of
subjects at greater CV risk and thus, a potential for cost-effective
prevention of major CV events.
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